Lineage Tracing Reveals the Dynamic Contribution of Pericytes to the Blood Vessel Remodeling in Pulmonary Hypertension

Archive ouverte

Bordenave, Jennifer | Tu, Ly | Berrebeh, Nihel | Thuillet, Raphaël | Cumont, Amélie | Le Vely, Benjamin | Fadel, Elie | Nadaud, Sophie | Savale, Laurent | Humbert, Marc | Huertas, Alice | Guignabert, Christophe

Edité par CCSD ; American Heart Association -

International audience. OBJECTIVE:Excessive accumulation of resident cells within the pulmonary vascular wall represents the hallmark feature of the remodeling occurring in pulmonary arterial hypertension (PAH). Furthermore, we have previously demonstrated that pulmonary arterioles are excessively covered by pericytes in PAH, but this process is not fully understood. The aim of our study was to investigate the dynamic contribution of pericytes in PAH vascular remodeling. Approach and Results: In this study, we performed in situ, in vivo, and in vitro experiments. We isolated primary cultures of human pericytes from controls and PAH lung specimens then performed functional studies (cell migration, proliferation, and differentiation). In addition, to follow up pericyte number and fate, a genetic fate-mapping approach was used with an NG2CreER;mT/mG transgenic mice in a model of pulmonary arteriole muscularization occurring during chronic hypoxia. We identified phenotypic and functional abnormalities of PAH pericytes in vitro, as they overexpress CXCR (C-X-C motif chemokine receptor)-7 and TGF (transforming growth factor)-βRII and, thereby, display a higher capacity to migrate, proliferate, and differentiate into smooth muscle-like cells than controls. In an in vivo model of chronic hypoxia, we found an early increase in pericyte number in a CXCL (C-X-C motif chemokine)-12-dependent manner whereas later, from day 7, activation of the canonical TGF-β signaling pathway induces pericytes to differentiate into smooth muscle-like cells.CONCLUSIONS:Our findings reveal a pivotal role of pulmonary pericytes in PAH and identify CXCR-7 and TGF-βRII as 2 intrinsic abnormalities in these resident progenitor vascular cells that foster the onset and maintenance of PAH structural changes in blood lung vessels.

Suggestions

Du même auteur

Serum and Pulmonary Uric Acid in Pulmonary Arterial Hypertension

Archive ouverte | Savale, Laurent | CCSD

International audience. Previous studies have suggested an association between uric acid (UA) and the severity of pulmonary arterial hypertension (PAH), but it is unknown whether UA contributes to disease pathogenes...

Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension

Archive ouverte | Poble, Paul-Benoit | CCSD

International audience. Heightened pulmonary artery smooth muscle cell (PA-SMC) proliferation and migration and dynamic remodeling of the extracellular matrix are hallmark pathogenic features of pulmonary arterial h...

Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension

Archive ouverte | Tu, Ly | CCSD

Comment inThe Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension. [Circ Res. 2019]Letter by Morrell et al Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary...

Chargement des enrichissements...